According to a new report, published by KBV research, The Global Coronary Heart Disease Diagnostic Imaging Devices Market size is expected to reach $2.1 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period.
The X rays market is showcasing a CAGR of 6.9% during (2022 - 2028). The increasing growth of this segment is owing to the lesser time consumption of the X-ray technique. Calcium can be detected in the heart or blood arteries using chest X-rays. Its occurrence could indicate the presence of lipids and other substances within the vessels of a patient, as well as damage to heart valves, heart muscle, coronary arteries, or the heart's protective sac.
The North America market dominated the Global Coronary Heart Disease Diagnostic Imaging Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $805.3 Million by 2028. The Europe market is estimated to witness a CAGR of 6.3% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 7.3% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/coronary-heart-disease-diagnostic-imaging-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).
By Geography
Companies Profiled
Unique Offerings 
